Michael Diem's most recent trade in Century Therapeutics Inc was a trade of 151,058 Common Stock done . Disclosure was reported to the exchange on May 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Michael Diem | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 151,058 | 274,296 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 123,238 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 101,363 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Michael Diem | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) |